Literature DB >> 29562984

Pre-treatment loss to follow-up of pulmonary tuberculosis patients in two regions of Cameroon.

E F Onyoh1, C Kuaban2, H-H Lin3.   

Abstract

SETTING: Thirty-nine tuberculosis diagnosis and treatment units (DTUs) in the North-West and South-West Regions of Cameroon.
OBJECTIVE: To determine the proportion of pre-treatment loss to follow-up (PLTFU) of bacteriologically confirmed pulmonary tuberculosis (PTB) patients and its risk factors.
DESIGN: A retrospective cohort study was conducted to retrieve information from the TB laboratory and treatment registers for all bacteriologically confirmed PTB patients diagnosed in the 39 DTUs during the last 6 months of 2015. PLTFU was defined as failure to initiate treatment within 7 days of diagnosis.
RESULTS: Among 1174 bacteriologically confirmed PTB cases, the proportion of PLTFU was 16.7% (95%CI 14.7-18.9). In the multivariable logistic regression model, travelling >30 km to the DTU was a risk factor for PLTFU (adjusted odds ratio [aOR] 2.31, 95%CI 1.63-3.27) compared with travelling 30 km. Travelling for >30 min to the DTU (aOR 2.19, 95%CI 1.56-3.09) and an urban location of DTU (aOR 2.51, 95%CI 1.51-4.17) were also significant risk factors for PLTFU.
CONCLUSION: PLTFU among TB patients remains a significant issue despite the availability of free anti-tuberculosis treatment in Cameroon. Diagnosed patients should be promptly and carefully linked to a treatment unit for treatment initiation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29562984     DOI: 10.5588/ijtld.17.0676

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  Differences in CT imaging signs between patients with tuberculosis and those with tuberculosis and concurrent lung cancer.

Authors:  Wencai Tang; Weijin Xing; Chuanzi Li; Zhongshi Nie; Mubin Cai
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

2.  Pre-treatment lost to follow-up tuberculosis patients, Chongwe, Zambia, 2017: a retrospective cohort study.

Authors:  M Chilembo; S Oguri; Y Matsuoka; M Ota; P Musiankuni; J Kabungo
Journal:  Public Health Action       Date:  2020-03-21

3.  Factors associated with loss to follow-up among TB patients in rural Papua New Guinea.

Authors:  I Umo; M Kulai; R J Commons
Journal:  Public Health Action       Date:  2021-12-21

4.  The Growing Importance of Tuberculosis Preventive Therapy and How Research and Innovation Can Enhance Its Implementation on the Ground.

Authors:  Anthony D Harries; Ajay M V Kumar; Srinath Satyanarayana; Pruthu Thekkur; Yan Lin; Riitta A Dlodlo; Mohammed Khogali; Rony Zachariah
Journal:  Trop Med Infect Dis       Date:  2020-04-16

5.  Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012-2019: Are We on the Right Track?

Authors:  Sharofiddin Yuldashev; Nargiza Parpieva; Salikhdjan Alimov; Laziz Turaev; Khasan Safaev; Kostyantyn Dumchev; Jamshid Gadoev; Oleksandr Korotych; Anthony D Harries
Journal:  Int J Environ Res Public Health       Date:  2021-04-28       Impact factor: 3.390

6.  Mobile targeted screening for tuberculosis in Zimbabwe: diagnosis, linkage to care and treatment outcomes.

Authors:  T Sengai; C Timire; A D Harries; H Tweya; F Kavenga; G Shumba; J Tavengerwei; R Ncube; C Zishiri; M J Mapfurira; V Mandizvidza; C Sandy
Journal:  Public Health Action       Date:  2019-12-21

Review 7.  What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030?

Authors:  Anthony D Harries; Yan Lin; Ajay M V Kumar; Srinath Satyanarayana; Kudakwashe C Takarinda; Riitta A Dlodlo; Rony Zachariah; Piero Olliaro
Journal:  F1000Res       Date:  2018-07-05

8.  Where are patients missed in the tuberculosis diagnostic cascade? A prospective cohort study in Ghana.

Authors:  Joyce B Der; Daniel Grint; Clement T Narh; Frank Bonsu; Alison D Grant
Journal:  PLoS One       Date:  2020-03-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.